Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global ...

Using an innovative and recently validated animal model of IBS, the researchers showed that opioid delta-receptor agonists ...

The delta opioid receptor (DOP) plays a key role in mood regulation, making it a promising target for therapeutic intervention. Studies have shown that selective DOP agonists (compounds that ...

Researchers have previously demonstrated antidepressant-like effects of delta opioid receptor agonists in rodents. In their latest study, they uncover the molecular and cellular mechanism ...

HURA READ THE FULL HURA RESEARCH REPORT We are initiating coverage of TuHURA Biosciences, Inc. (NASDAQ:HURA) with a valuation of $9.25 per share. This value is based on our estimates for successful ...

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

Opioid use during pregnancy—whether of highly addictive drugs like fentanyl or controlled opioids like buprenorphine—doubles ...

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, ...

Investment analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company ...